Clinic alleges “market-allocation” for erectile dysfunction treatment
Credit: Shutterstock/Cholpan
Two rival providers of erectile dysfunction treatments have allocated the market for their services through an anticompetitive licensing settlement and baseless patent infringement claims, a medical clinic has alleged.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10